Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
Clinical trial NCT02969837 · COMPLETED
Trial details
- NCT number
- NCT02969837
- Sponsor
- University of Chicago
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-10
- Primary completion
- 2021-10-11
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.